Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Non-cash Items: 2021-2022

Historic Non-cash Items for Immuneering (IMRX) over the last 2 years, with Dec 2022 value amounting to $2.7 million.

  • Immuneering's Non-cash Items fell 90.17% to $2.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $2.7 million, marking a year-over-year decrease of 90.17%. This contributed to the annual value of $2.7 million for FY2022, which is 90.17% down from last year.
  • Per Immuneering's latest filing, its Non-cash Items stood at $2.7 million for Q4 2022, which was down 89.51% from $25.9 million recorded in Q3 2022.
  • Immuneering's 5-year Non-cash Items high stood at $56.3 million for Q3 2021, and its period low was $2.7 million during Q4 2022.
  • Moreover, its 2-year median value for Non-cash Items was $11.5 million (2021), whereas its average is $19.0 million.
  • Data for Immuneering's Non-cash Items shows a maximum YoY plummeted of 90.17% (in 2022) over the last 5 years.
  • Immuneering's Non-cash Items (Quarterly) stood at $27.6 million in 2021, then crashed by 90.17% to $2.7 million in 2022.
  • Its Non-cash Items stands at $2.7 million for Q4 2022, versus $25.9 million for Q3 2022 and $3.7 million for Q2 2022.